University of Texas MD Anderson Cancer Center:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:University of Texas MD Anderson Cancer Center - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C11412
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Texas MD Anderson Cancer Center (MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Anderson provides cancer treatment, cancer research, education and research-based prevention of both common and rare cancers in adult and pediatric patients. Its departments include cancer biology, cancer medicine, cancer systems imaging, cancer prevention and population sciences, clinical cancer prevention, general oncology, hematopathology, gastroenterology, hepatology and nutrition, and genitourinary medical oncology, among others. MD Anderson offers undergraduate, graduate and post-graduate programs, besides research training and nursing education. It operates various research centers, labs and facilities across Texas, New Mexico and New Jersey, the US; Turkey; and Spain. MD Anderson is headquartered in Houston, Texas, the US.

University of Texas MD Anderson Cancer Center – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Texas MD Anderson Cancer Center, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
University of Texas MD Anderson Cancer Center, Medical Equipment Deals By Type, 2012 to YTD 2018 7
University of Texas MD Anderson Cancer Center, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
University of Texas MD Anderson Cancer Center, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
University of Texas MD Anderson Cancer Center, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
University of Texas MD Anderson Cancer Center, Medical Equipment, Deal Details 11
Partnerships 11
Myriad Genetics Enters into Licensing Agreement with University of Texas 11
University of Texas MD Anderson and Raysearch Lab Enter into Agreement 12
Oncora Medical and MD Anderson Cancer Center Enter into Agreement 13
University of Texas MD Anderson Cancer Center Enters into Agreement with Guardant Health 14
Signal Genetics Enters into Research Agreement with University of Texas MD Anderson Cancer Center 15
Kiromic Enters into Agreement with University of Texas MD Anderson Cancer Center 16
HTG Molecular Diagnostics Enters into Research Agreement with University of Texas MD Anderson Cancer Center 17
NanoString Enters into Co-Development Agreement with MD Anderson Cancer Center 18
Angle Enters into Agreement with MD Anderson Cancer Center 19
University of Texas MD Anderson Cancer Center – Key Competitors 20
University of Texas MD Anderson Cancer Center – Key Employees 21
University of Texas MD Anderson Cancer Center – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 24
Recent Developments 25
Strategy And Business Planning 25
Feb 26, 2018: MD Anderson and RaySearch announce strategic alliance to advance radiation therapy of cancer 25
Nov 29, 2017: Summit Medical Group MD Anderson Cancer Center Opens Radiation Oncology Department; Provides Full Spectrum Of Cancer Care To Patients In Northern New Jersey 26
Corporate Communications 27
May 08, 2018: Van Andel Research Institute expands cancer research program 27
Nov 29, 2017: Summit Medical Group MD Anderson Cancer Center Opens Radiation Oncology Department; Provides Full Spectrum Of Cancer Care To Patients In Northern New Jersey 28
Government and Public Interest 29
Sep 13, 2018: Largest-Ever Study Shows Silicone Breast Implants Associated with Rare Diseases 29
Jul 12, 2018: Study shows biomarker panel boosts lung cancer risk assessment for smokers 31
May 16, 2018: Self-reporting with sensor and mobile technology may reduce symptom burden for head and neck cancer patients undergoing radiation treatment 33
Product News 34
Apr 15, 2018: New liquid biopsy-based cancer model reveals data on deadly lung cancer 34
Jul 20, 2017: Concurrent chemotherapy, proton therapy improves survival in patients with advanced lung cancer 36
Mar 17, 2017: Advanced form of proton therapy shows promise for treating lung cancer recurrence 38
Other Significant Developments 40
Jul 12, 2018: Blood test can help identify the target population to screen for lung cancer 40
Oct 19, 2017: CLS signs supplier agreement with University of Texas Medical Branch and receives the first order 41
Apr 04, 2017: MD Anderson, Oncora Medical team up to fight cancer with precision medicine alliance 42
Jan 30, 2017: C-RAD and MD Anderson Cancer Center concluded agreement to supply innovative SIGRT solution 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
University of Texas MD Anderson Cancer Center, Medical Equipment, Key Facts, 2017 2
University of Texas MD Anderson Cancer Center, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
University of Texas MD Anderson Cancer Center, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
University of Texas MD Anderson Cancer Center, Medical Equipment Deals By Type, 2012 to YTD 2018 7
University of Texas MD Anderson Cancer Center, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
University of Texas MD Anderson Cancer Center, Deals By Market, 2012 to YTD 2018 9
University of Texas MD Anderson Cancer Center, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Myriad Genetics Enters into Licensing Agreement with University of Texas 11
University of Texas MD Anderson and Raysearch Lab Enter into Agreement 12
Oncora Medical and MD Anderson Cancer Center Enter into Agreement 13
University of Texas MD Anderson Cancer Center Enters into Agreement with Guardant Health 14
Signal Genetics Enters into Research Agreement with University of Texas MD Anderson Cancer Center 15
Kiromic Enters into Agreement with University of Texas MD Anderson Cancer Center 16
HTG Molecular Diagnostics Enters into Research Agreement with University of Texas MD Anderson Cancer Center 17
NanoString Enters into Co-Development Agreement with MD Anderson Cancer Center 18
Angle Enters into Agreement with MD Anderson Cancer Center 19
University of Texas MD Anderson Cancer Center, Key Competitors 20
University of Texas MD Anderson Cancer Center, Key Employees 21
University of Texas MD Anderson Cancer Center, Other Locations 22
University of Texas MD Anderson Cancer Center, Subsidiaries 23
University of Texas MD Anderson Cancer Center, Joint Venture 24

List of Figures
University of Texas MD Anderson Cancer Center, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
University of Texas MD Anderson Cancer Center, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
University of Texas MD Anderson Cancer Center, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
University of Texas MD Anderson Cancer Center, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
University of Texas MD Anderson Cancer Center, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
University of Texas MD Anderson Cancer Center, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
University of Texas MD Anderson Cancer Center, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
University of Texas MD Anderson Cancer Center, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[University of Texas MD Anderson Cancer Center:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • National Petrochemical Co (2002):企業の財務・戦略的SWOT分析
    Summary National Petrochemical Co (Petrochem), a subsidiary of Saudi Industrial Investment Group, is a petrochemical company that invests and develops petrochemical industry. The company provides activities such as development and establishment, operation, management and maintenance of petrochemical …
  • Netsmart Technologies Inc:企業の戦略的SWOT分析
    Netsmart Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Luye Pharma Group Ltd (2186):企業の財務・戦略的SWOT分析
    Summary Luye Pharma Group Ltd (Luye Pharma), a subsidiary of Luye Life Sciences Group Ltd is a drug development company that discovers, manufactures, and commercializes novel formulations, generic drugs, and pharmaceutical products. The company offers its products in the form of tablets, formulation …
  • RIKEN-製薬・医療分野:企業M&A・提携分析
    Summary RIKEN is a research organization, which carries out research in basic and applied sciences. Its research system consists of strategic research centers, research infrastructure centers, chief scientist system, etc. and a cluster for industry partnerships. Its centers, laboratories and researc …
  • Long Run Exploration Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Long Run Exploration Ltd (Long Run), formerly WestFire Energy Ltd, a subsidiary of Calgary Sinoenergy Investment Corp, is an oil and gas company that offers development and exploration of light oil. The company grows crude oil volumes within its diversified portfolio properties. Its oil expl …
  • University of Leicester-製薬・医療分野:企業M&A・提携分析
    Summary University of Leicester (UOL) is an educational service provider that offers undergraduate, postgraduate, distance learning and part-time programs. The university offers educational and research services in various disciplines such as mathematics, biochemistry, medicine, astrophysics, geneti …
  • PharmaZell GmbH:企業の戦略的SWOT分析
    PharmaZell GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • J. Knipper and Company Inc:企業の戦略的SWOT分析
    J. Knipper and Company Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Meiji Holdings Co, Ltd.:戦略・SWOT・企業財務分析
    Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • DIC Corp (4631):企業の財務・戦略的SWOT分析
    DIC Corp (4631) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Norgine BV:企業の戦略的SWOT分析
    Norgine BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • MabVax Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary MabVax Therapeutics Inc (MabVax Therapeutics), a subsidiary of MabVax Therapeutics Holdings Inc is a biopharmaceutical company that develops and commercializes anti-cancer immunotherapies from antibody and vaccine technology. The company offers immune-oncology technology platforms such as hu …
  • Assembly Biosciences Inc (ASMB):企業の財務・戦略的SWOT分析
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium diffic …
  • ICF International Inc (ICFI):企業の財務・戦略的SWOT分析
    ICF International Inc (ICFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • The Ultimate Software Group, Inc. (ULTI):企業の財務・戦略的SWOT分析
    The Ultimate Software Group, Inc. (ULTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Smiths Group plc:戦略・SWOT・企業財務分析
    Smiths Group plc - Strategy, SWOT and Corporate Finance Report Summary Smiths Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • ON Semiconductor Corporation:企業の戦略・SWOT・財務情報
    ON Semiconductor Corporation - Strategy, SWOT and Corporate Finance Report Summary ON Semiconductor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Cardiva Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cardiva Medical Inc (Cardiva) designs, develops and commercializes of vascular access management products. The major products of the company include VASCADE vascular closure system (VCS) for femoral arterial access site closure post-diagnostic and interventional endovascular procedures; and …
  • Mytilineos Holdings Sa:企業の戦略・SWOT・財務分析
    Mytilineos Holdings Sa - Strategy, SWOT and Corporate Finance Report Summary Mytilineos Holdings Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Genzyme Corp-製薬・医療分野:企業M&A・提携分析
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty treatments targeting rare and special unmet medical needs. Its product pipeline comprises Dupilumab for atopic dermatitis and asthma; Patisiran for familial amyloid polyneuropathy; Isatuximab f …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆